{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:34Z","timestamp":1792801474725,"version":"4.5.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.neuro.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T11:06:40Z","timestamp":1418468800000},"page":"101-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":313,"special_numbering":"C","title":["An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene\u2013environment interactions"],"prefix":"10.1016","volume":"46","author":[{"given":"Michaela E.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Bobrovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2014.12.002_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2014.12.002_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/01.wnl.0000271080.53272.c7","article-title":"\u03b1-Synuclein gene duplication is present in sporadic Parkinson disease","volume":"70","author":"Ahn","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbr.2003.08.014","article-title":"The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by l-DOPA","volume":"151","author":"Alam","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces Parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.physbeh.2004.08.010","article-title":"Mitochondrial complex I inhibition depletes plasma testosterone in the rotenone model of Parkinson's disease","volume":"83","author":"Alam","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuro.2014.12.002_bib0030","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.1523\/JNEUROSCI.0979-08.2008","article-title":"Loss of PINK1 function affects development and results in neurodegeneration in zebrafish","volume":"28","author":"Anichtchik","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0006-8993(02)02551-9","article-title":"Protective effect of melatonin in a chronic experimental model of Parkinson's disease","volume":"943","author":"Antolin","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2006.07.057","article-title":"Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons","volume":"1113","author":"Bai","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2010.11.008","article-title":"Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease","volume":"17","author":"Bardien","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2014.09.068","article-title":"Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats","author":"Bassani","year":"2014","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, \u03b1-synuclein, and the ubiquitin\u2013proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson's disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.neuro.2014.12.002_bib0065","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuro.2014.12.002_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.wnl.0000167546.39375.82","article-title":"Early-onset Parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes","volume":"65","author":"Bonifati","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0080","first-page":"15","article-title":"Nigral and extranigral pathology in Parkinson's disease","volume":"46","author":"Braak","year":"1995","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuro.2014.12.002_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2014.12.002_bib0090","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","article-title":"Invited article: nervous system pathology in sporadic Parkinson disease","volume":"70","author":"Braak","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2014.12.002_bib0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ntt.2004.06.014","article-title":"Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease","volume":"26","author":"Bretaud","year":"2004","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mds.10114","article-title":"Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease","volume":"17","author":"Burn","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2012.11.007","article-title":"Expression of human E46K-mutated alpha-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment","volume":"240","author":"Cannon","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2014.02.028","article-title":"Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease","volume":"267","author":"Carriere","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0125","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/mds.22051","article-title":"Neural control of the gastrointestinal tract: implications for Parkinson disease","volume":"23","author":"Cersosimo","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0130","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","article-title":"Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms","volume":"260","author":"Cersosimo","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0135","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10571-013-9959-y","article-title":"Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice","volume":"33","author":"Chandran","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0140","series-title":"Behavior and its neural control in gastropod molluscs","author":"Chase","year":"2002"},{"key":"10.1016\/j.neuro.2014.12.002_bib0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0150","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M509079200","article-title":"Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases","volume":"281","author":"Choi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0160","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2014.12.002_bib0165","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1523\/JNEUROSCI.2993-04.2004","article-title":"Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster","volume":"24","author":"Coulom","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0170","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.54.5.21A","article-title":"Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"de Rijk","year":"2000","journal-title":"Neurology"},{"issue":"Suppl. 3","key":"10.1016\/j.neuro.2014.12.002_bib0175","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","article-title":"Neuropathology of non-motor features of Parkinson disease","volume":"15","author":"Dickson","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0180","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jnr.23258","article-title":"REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson's disease","volume":"91","author":"Dos Santos","year":"2013","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.nbd.2011.10.026","article-title":"Olfaction in Parkinson's disease and related disorders","volume":"46","author":"Doty","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","article-title":"Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology","volume":"36","author":"Drolet","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.870060211","article-title":"Gastrointestinal symptoms in Parkinson's disease","volume":"6","author":"Edwards","year":"1991","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","article-title":"GFAP and astrogliosis","volume":"4","author":"Eng","year":"1994","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0210","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1523\/JNEUROSCI.0719-07.2007","article-title":"Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin","volume":"27","author":"Exner","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0215","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2014.12.002_bib0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(03)00201-0","article-title":"Parkin: a multipurpose neuroprotective agent","volume":"38","author":"Feany","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2014.12.002_bib0225","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2012.09.024","article-title":"Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease","volume":"438","author":"Fernandez","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.neuro.2014.12.002_bib0230","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2011.07.029","article-title":"An effective novel delivery strategy of rasagiline for Parkinson's disease","volume":"419","author":"Fernandez","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.neuro.2014.12.002_bib0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/brb3.138","article-title":"A phenotypic model recapitulating the neuropathology of Parkinson's disease","volume":"3","author":"Ferris","year":"2013","journal-title":"Brain Behav"},{"key":"10.1016\/j.neuro.2014.12.002_bib0240","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/03632415.2012.723963","article-title":"Rotenone use in fish management and Parkinson's disease: another look","volume":"37","author":"Finlayson","year":"2012","journal-title":"Fisheries"},{"key":"10.1016\/j.neuro.2014.12.002_bib0245","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0250","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1471-4159.2008.05463.x","article-title":"Zebrafish as a new animal model for movement disorders","volume":"106","author":"Flinn","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0255","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/brain\/awp108","article-title":"Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio)","volume":"132","author":"Flinn","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2014.12.002_bib0260","doi-asserted-by":"crossref","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2014.12.002_bib0265","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson's disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.brainres.2005.02.036","article-title":"Sleep disturbances in the rotenone animal model of Parkinson disease","volume":"1042","author":"Garcia-Garcia","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0275","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s004150170066","article-title":"Genetics of Parkinson's disease","volume":"248","author":"Gasser","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12031-010-9378-1","article-title":"\u03b1-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced \u03b1-synuclein and PINK1 levels after rotenone treatment","volume":"42","author":"George","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0285","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuro.2012.04.002","article-title":"Propensity of Selaginella delicatula aqueous extract to offset rotenone-induced oxidative dysfunctions and neurotoxicity in Drosophila melanogaster: implications for Parkinson's disease","volume":"33","author":"Girish","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0290","doi-asserted-by":"crossref","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2014.12.002_bib0295","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s11064-014-1323-1","article-title":"Oral supplements of aqueous extract of tomato seeds alleviate motor abnormality, oxidative impairments and neurotoxicity induced by rotenone in mice: relevance to Parkinson's disease","volume":"39","author":"Gokul","year":"2014","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tips.2009.12.006","article-title":"Lessons from the rotenone model of Parkinson's disease","volume":"31","author":"Greenamyre","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0305","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","article-title":"Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease","volume":"218","author":"Greene","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0310","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mds.23669","article-title":"Milestones in Parkinson's disease \u2013 clinical and pathologic features","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0315","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2014.12.002_bib0320","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.20251","article-title":"Novel PINK1 mutations in early-onset Parkinsonism","volume":"56","author":"Hatano","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0325","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson's disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0330","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1046\/j.1471-4159.2003.01938.x","article-title":"Role of nitric oxide in rotenone-induced nigrostriatal injury","volume":"86","author":"He","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0335","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.WNL.0000113022.51739.88","article-title":"DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease","volume":"62","author":"Hedrich","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0340","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","article-title":"Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"62","author":"Heikkila","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2014.12.002_bib0345","first-page":"83","article-title":"Rotenone-potential and prospect for sustainable agriculture","volume":"11","author":"Hien","year":"2003","journal-title":"Omonrice"},{"key":"10.1016\/j.neuro.2014.12.002_bib0350","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0355","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-4159.2005.03493.x","article-title":"The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy","volume":"95","author":"Hoglinger","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-211-45295-0_41","article-title":"The rotenone model of Parkinsonism \u2013 the five years inspection","volume":"70","author":"Hoglinger","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuro.2014.12.002_bib0365","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuro.2009.08.012","article-title":"Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster","volume":"30","author":"Hosamani","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0370","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s11064-010-0198-z","article-title":"Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicity in Drosophila melanogaster supplemented with creatine","volume":"35","author":"Hosamani","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0375","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.biomaterials.2005.07.005","article-title":"A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease","volume":"27","author":"Huang","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.neuro.2014.12.002_bib0380","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.22009","article-title":"Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients","volume":"23","author":"Huisman","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0385","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mds.10713","article-title":"A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease","volume":"19","author":"Huisman","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0390","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nbd.2014.05.032","article-title":"The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease","volume":"69","author":"Hwang","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0395","doi-asserted-by":"crossref","first-page":"35661","DOI":"10.1074\/jbc.C000447200","article-title":"Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity","volume":"275","author":"Imai","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0400","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1248\/bpb.34.92","article-title":"Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL\/6 mice","volume":"34","author":"Inden","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neuro.2014.12.002_bib0405","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","article-title":"Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone","volume":"101","author":"Inden","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nbd.2011.12.055","article-title":"A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model","volume":"46","author":"Islam","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0415","first-page":"940","article-title":"Neuroprotective activity of Stachytrapheta indica on rotenone induced Parkinson's disease in zebrafish","volume":"3","author":"Jayanth","year":"2014","journal-title":"World J Pharm Pharm Sci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0420","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2011.04.012","article-title":"Synuclein deposition and non-motor symptoms in Parkinson disease","volume":"310","author":"Jellinger","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0425","doi-asserted-by":"crossref","first-page":"e91641","DOI":"10.1371\/journal.pone.0091641","article-title":"Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice","volume":"9","author":"Jia","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.neuro.2014.12.002_bib0430","first-page":"143547","article-title":"Neurobiology of depression and anxiety in Parkinson's disease","volume":"2011","author":"Kano","year":"2011","journal-title":"Parkinson's Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0435","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.01.032","article-title":"Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats","volume":"236","author":"Karuppagounder","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0440","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11064-011-0469-3","article-title":"Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease","volume":"36","author":"Kaur","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0445","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2014.12.002_bib0450","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.03-0677fje","article-title":"Rotenone induces non-specific central nervous system and systemic toxicity","volume":"18","author":"Lapointe","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.neuro.2014.12.002_bib0455","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2010.05.008","article-title":"The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons","volume":"40","author":"Lawal","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0460","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/07420528.2011.649870","article-title":"Circadian dysfunction in a rotenone-induced parkinsonian rodent model","volume":"29","author":"Lax","year":"2012","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.neuro.2014.12.002_bib0465","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/gut.2008.162503","article-title":"Pathological lesions in colonic biopsies during Parkinson's disease","volume":"57","author":"Lebouvier","year":"2008","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.neuro.2014.12.002_bib0470","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S1353-8020(11)70022-0","article-title":"Role of Mendelian genes in sporadic Parkinson's disease","volume":"18","author":"Lesage","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0475","series-title":"Handbuch der neurologie","article-title":"Paralysis agitans: I. Pathologische anatomie","author":"Lewy","year":"1912"},{"key":"10.1016\/j.neuro.2014.12.002_bib0480","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.smrv.2012.10.006","article-title":"Sleep disturbances in Parkinson's disease: the contribution of dopamine in REM sleep regulation","volume":"17","author":"Lima","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neuro.2014.12.002_bib0485","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0490","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1326-9-23","article-title":"Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2)","volume":"9","author":"Linhart","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neuro.2014.12.002_bib0495","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1038\/sj.emboj.7600451","article-title":"alpha-Synuclein produces a long-lasting increase in neurotransmitter release","volume":"23","author":"Liu","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.neuro.2014.12.002_bib0500","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"L\u00fccking","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuro.2014.12.002_bib0505","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/syn.21658","article-title":"Sodium salicylate protects against rotenone-induced Parkinsonism in rats","volume":"67","author":"Madathil","year":"2013","journal-title":"Synapse"},{"key":"10.1016\/j.neuro.2014.12.002_bib0510","doi-asserted-by":"crossref","first-page":"e1433","DOI":"10.1371\/journal.pone.0001433","article-title":"Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease","volume":"3","author":"Marella","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2014.12.002_bib0515","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuron.2006.09.025","article-title":"Drosophila in the study of neurodegenerative disease","volume":"52","author":"Marsh","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2014.12.002_bib0520","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/ars.2011.4033","article-title":"Toxin models of mitochondrial dysfunction in Parkinson's disease","volume":"16","author":"Martinez","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.neuro.2014.12.002_bib0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2011.05.006","article-title":"The importance of non-motor disturbances to quality of life in Parkinson's disease","volume":"310","author":"Martinez-Martin","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0530","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.cub.2005.07.064","article-title":"Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease","volume":"15","author":"Meulener","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0535","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/hmg\/ddl030","article-title":"Multiple candidate gene analysis identifies \u03b1-synuclein as a susceptibility gene for sporadic Parkinson's disease","volume":"15","author":"Mizuta","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0540","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2010.03.019","article-title":"Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease","volume":"40","author":"Mocko","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0545","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1734-1140(12)70905-2","article-title":"Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration","volume":"64","author":"Morais","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neuro.2014.12.002_bib0550","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(01)03106-7","article-title":"Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway","volume":"921","author":"Morgan","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0555","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2011.12.011","article-title":"Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-\u03b1-synuclein and the pesticide, rotenone","volume":"203","author":"Mulcahy","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0560","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbr.2012.12.051","article-title":"The behavioural and neuropathological impact of intranigral AAV-\u03b1-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats","volume":"243","author":"Mulcahy","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0565","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2011.01.038","article-title":"Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone","volume":"181","author":"Mulcahy","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0570","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-011-0830-2","article-title":"Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders","volume":"122","author":"Mundinano","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0575","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12640-014-9480-1","article-title":"Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in Parkinsonian mice","volume":"26","author":"Murakami","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0580","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2010.07.076","article-title":"MPTP-induced Parkinsonism extends to a subclass of TH-positive neurons in the gut","volume":"1355","author":"Natale","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0585","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/jnc.12818","article-title":"Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila","volume":"131","author":"Navarro","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0590","doi-asserted-by":"crossref","first-page":"11257","DOI":"10.1523\/JNEUROSCI.2375-09.2009","article-title":"Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila","volume":"29","author":"Ng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0595","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/mds.22682","article-title":"Expanding the clinical phenotype of SNCA duplication carriers","volume":"24","author":"Nishioka","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0600","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neuro.2014.12.002_bib0605","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/01.WNL.0000106840.72938.84","article-title":"Plasma testosterone levels in Alzheimer and Parkinson diseases","volume":"62","author":"Okun","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0610","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archneur.59.5.807","article-title":"Refractory non-motor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity","volume":"59","author":"Okun","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0615","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0620","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","article-title":"Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-Montojo","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2014.12.002_bib0625","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","article-title":"Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes","volume":"23","author":"Pandi-Perumal","year":"2013","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0630","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2014.12.002_bib0635","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2202-6-71","article-title":"Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity","volume":"6","author":"Perez","year":"2005","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0640","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0645","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1523\/JNEUROSCI.3730-10.2011","article-title":"LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool","volume":"31","author":"Piccoli","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0650","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuro.2014.12.002_bib0655","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12640-011-9281-8","article-title":"Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease","volume":"21","author":"Prediger","year":"2012","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0660","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vascn.2007.10.003","article-title":"The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK\u2013PD experiments","volume":"57","author":"Ravenstijn","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuro.2014.12.002_bib0665","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1038\/cddis.2013.513","article-title":"Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model","volume":"5","author":"Ray","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0670","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fncel.2014.00383","article-title":"Olfactory impairment in the rotenone model of Parkinson's disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation","volume":"8","author":"Rodrigues","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0675","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.20247","article-title":"Homozygous PINK1 C-terminus mutation causing early-onset Parkinsonism","volume":"56","author":"Roh\u00e9","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0960","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.neuroscience.2009.07.012","article-title":"Striatal neuroprotection with methylene blue","volume":"163","author":"Rojas","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0680","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2007.07.022","article-title":"Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats","volume":"208","author":"Rojo","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0685","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.21405","article-title":"Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease","volume":"64","author":"Ross","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0690","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00429-009-0237-1","article-title":"Transgenic zebrafish models of neurodegenerative diseases","volume":"214","author":"Sager","year":"2010","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.neuro.2014.12.002_bib0695","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1523\/JNEUROSCI.2281-09.2009","article-title":"LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans","volume":"29","author":"Saha","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0700","doi-asserted-by":"crossref","first-page":"e24558","DOI":"10.4161\/worm.24558","article-title":"A microfluidic phenotype analysis system reveals function of sensory and dopaminergic neuron signaling in C. elegans electrotactic swimming behavior","volume":"2","author":"Salam","year":"2013","journal-title":"Worm"},{"key":"10.1016\/j.neuro.2014.12.002_bib0705","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/1871527311201070836","article-title":"Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease","volume":"11","author":"Salama","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neuro.2014.12.002_bib0710","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuro.2014.12.002_bib0715","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2005.04.051","article-title":"Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease","volume":"1049","author":"Saravanan","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0720","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuro.2014.12.002_bib0725","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5607\/en.2013.22.3.214","article-title":"Beneficial effect of vitamin E in rotenone induced model of PD: behavioural, neurochemical and biochemical study","volume":"22","author":"Sharma","year":"2013","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0730","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0735","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0740","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0745","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0750","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0755","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddi377","article-title":"Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism","volume":"14","author":"Silvestri","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0760","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.05.051","article-title":"Behavioral differences in a rotenone-induced hemi-Parkinsonian rat model developed following intranigral or median forebrain bundle infusion","volume":"1051","author":"Sindhu","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0765","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0770","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1289\/ehp.7614109","article-title":"Naturally occurring insecticides","volume":"14","author":"Soloway","year":"1976","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuro.2014.12.002_bib0775","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuroscience.2012.06.021","article-title":"Rotenone-induced Parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat","volume":"220","author":"Sonia Angeline","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0780","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuroscience.2013.09.029","article-title":"Sesamol and naringenin reverse the effect of rotenone-induced PD rat model","volume":"254","author":"Sonia Angeline","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0785","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease","volume":"246","author":"St Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0790","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinsphys.2014.04.005","article-title":"Role of Bacopa monnieri in the temporal regulation of oxidative stress in clock mutant (cryb) of Drosophila melanogaster","volume":"65","author":"Subramanian","year":"2014","journal-title":"J Insect Physiol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0795","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuro.2013.04.006","article-title":"Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster","volume":"37","author":"Sudati","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2014.12.002_bib0800","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.mito.2013.02.004","article-title":"Caenorhabditis elegans ATR checkpoint kinase ATL-1 influences life span through mitochondrial maintenance","volume":"13","author":"Suetomi","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neuro.2014.12.002_bib0805","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00439-008-0544-2","article-title":"LRRK2 R1628P increases risk of Parkinson's disease: replication evidence","volume":"124","author":"Tan","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0810","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mds.20810","article-title":"PINK1 mutations in sporadic early-onset Parkinson's disease","volume":"21","author":"Tan","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0815","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuro.2014.12.002_bib0820","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0825","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neurobiolaging.2013.10.077","article-title":"Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease","volume":"35","author":"Tapias","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2014.12.002_bib0830","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/nmo.12070","article-title":"Effects of oral administration of rotenone on gastrointestinal functions in mice","volume":"25","author":"Tasselli","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.neuro.2014.12.002_bib0835","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neuroscience.2012.11.006","article-title":"Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease","volume":"231","author":"Thakur","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.12.002_bib0840","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/hmg\/ddq430","article-title":"DJ-1 acts in parallel to the PINK1\/parkin pathway to control mitochondrial function and autophagy","volume":"20","author":"Thomas","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0845","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1004676107","article-title":"Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice","volume":"107","author":"Tong","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2014.12.002_bib0850","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuro.2014.12.002_bib0855","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.20256","article-title":"PINK1 mutations are associated with sporadic early-onset Parkinsonism","volume":"56","author":"Valente","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0860","doi-asserted-by":"crossref","first-page":"42655","DOI":"10.1074\/jbc.M505910200","article-title":"Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans","volume":"280","author":"Ved","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.12.002_bib0865","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/j.1460-9568.2007.05467.x","article-title":"Behavioural and neural deficits induced by rotenone in the pond snail Lymnaea stagnalis: a possible model for Parkinson's disease in an invertebrate","volume":"25","author":"Vehovszky","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0870","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1093\/hmg\/ddp394","article-title":"Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease","volume":"18","author":"Venderova","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0875","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0880","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1523\/JNEUROSCI.0218-07.2007","article-title":"Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities","volume":"27","author":"Wang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2014.12.002_bib0885","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-3-3","article-title":"Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons","volume":"3","author":"Wang","year":"2008","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neuro.2014.12.002_bib0890","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1111\/j.1742-4658.2009.07342.x","article-title":"LRRK2 in Parkinson's disease: function in cells and neurodegeneration","volume":"276","author":"Webber","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.neuro.2014.12.002_bib0895","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000113697","article-title":"Investigating convergent actions of genes linked to familial Parkinson's disease","volume":"5","author":"Wolozin","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0900","series-title":"The nematode Caenorhabditis elegans","author":"Wood","year":"1987"},{"key":"10.1016\/j.neuro.2014.12.002_bib0905","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neulet.2013.06.008","article-title":"Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease","volume":"548","author":"Wu","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2014.12.002_bib0910","doi-asserted-by":"crossref","first-page":"e7878","DOI":"10.1371\/journal.pone.0007878","article-title":"Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease","volume":"4","author":"Xiong","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2014.12.002_bib0915","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/10408444.2012.680431","article-title":"Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models","volume":"42","author":"Xiong","year":"2012","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0920","doi-asserted-by":"crossref","first-page":"e1000902","DOI":"10.1371\/journal.pgen.1000902","article-title":"GTPase activity plays a key role in the pathobiology of LRRK2","volume":"6","author":"Xiong","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.neuro.2014.12.002_bib0925","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1038\/cddis.2009.4","article-title":"Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease","volume":"1","author":"Yacoubian","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neuro.2014.12.002_bib0930","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/sleep\/30.4.413","article-title":"Interleukin-1beta mediates sleep alteration in rats with rotenone-induced Parkinsonism","volume":"30","author":"Yi","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.neuro.2014.12.002_bib0935","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12640-014-9467-y","article-title":"Antidepressant and antioxidative effect of ibuprofen in the rotenone model of Parkinson's disease","volume":"26","author":"Zaminelli","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuro.2014.12.002_bib0940","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","article-title":"Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2014.12.002_bib0945","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/mds.22371","article-title":"LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China","volume":"24","author":"Zhang","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2014.12.002_bib0950","first-page":"191","article-title":"Caenorhabditis elegans neuron degeneration and mitochondrial suppression caused by selected environmental chemicals","volume":"4","author":"Zhou","year":"2013","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1016\/j.neuro.2014.12.002_bib0955","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease","volume":"89","author":"Zimprich","year":"2011","journal-title":"Am J Hum Genet"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14002174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14002174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T07:14:15Z","timestamp":1650784455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X14002174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":192,"alternative-id":["S0161813X14002174"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2014.12.002","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene\u2013environment interactions","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}